PGY2 Oncology Pharmacy Residency
Purpose of the Residency Program
PGY2 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification, if available
This specialty residency program will provide advanced training for pharmacists in the fields of oncology, hematology, and blood and marrow transplantation. The resident will have the opportunity to work as an integral member within a multidisciplinary team to actively provide optimal pharmaceutical care for these complex patient populations. In addition, residents will participate in developing and supporting quality improvement initiatives, contribute to research efforts in the field, precept PGY1 pharmacy residents and pharmacy students, conduct self-assessment for professional development, and commit to continuous self-learning. The various components of this residency program shall be continuously evaluated to ensure the quality of each experience. As institutional and/or organizational dynamics change, revisions and modifications of the program may be necessary to fulfill the original established program goals.
Residency Program Director
Residency Program Coordinator